Gapping down
News:
- ITRM -41.7% (receives deficiency letter from FDA)
- ARWR -25.8% (notified regulatory agencies, institutional review boards, and investigators that effective immediately it is voluntarily pausing AROENaC1001, a Phase 1/2 clinical study of ARO-ENaC)
- BSGM -9.2% (stock offering)
- DIDI -8% (Cyberspace Administration of China launches new cyber security investigation of DIDI; regulator asks DIDI to halt new user registration during investigatio)
- MLSS -3.4% (Milestone Scientific announced that Scott Kahn, the Chief Financial Officer, and the Company have reached a mutual decision to part ways)
- CSSE -2.7% (stock offering)
- CERE -1.5% (prices offering of 14 mln shares of common stock at $25.00 per share)
- SAN -1.5% (Banco Santander announces proposal to acquire shares it does not own of Santander Consumer USA Holdings (SC) for $39.00/share)
- CLVT -1% (files for mixed securities shelf offering)
Analyst comments:
- WBT -2.1% (downgraded to Neutral from Buy at CL King)
- KEYS -1.4% (downgraded to Equal Weight from Overweight at Barclays)